Novavax (NASDAQ:NVAX) surges 35% this week, taking five-year gains to 171%
(NASDAQ:NVAX) shareholders might be concerned after seeing the share price drop 15% in the last quarter. But that scarcely detracts from the really solid long term returns generated by the company ...
Nasdaq8d
NVAX February 14th Options Begin Trading
Investors in Novavax, Inc. (Symbol: NVAX) saw new options begin trading today, for the February 14th expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the NVAX ...
Moderna, Novavax and other vaccine names extend gains amid COVID/flu concerns
Novavax (NVAX) and other vaccine developers rise as Investors react to rising flu and COVID-19 cases in the U.S. Read more ...
Nasdaq17d
Novavax, Inc. (NVAX) Is a Trending Stock: Facts to Know Before Betting on It
Novavax (NVAX) is one of the stocks most watched by Zacks.com visitors lately. So, it might be a good idea to review some of the factors that might affect the near-term performance of the stock.
Yahoo Finance1d
Novavax, Inc. (NVAX)
But the company trimmed its outlook. Is NVAX stock a sell in December 2024? Novavax, Inc. (Nasdaq: NVAX), a global company advancing protein-based vaccines with its Matrix-M™ adjuvant ...
Vaccine Stocks Surge: Moderna Jumps 11% as COVID-19 and Flu Fears Reignite Immunization Demand
Moderna leads vaccine rally amid rising respiratory infections, spurring investment in COVID-19, flu, and RSV solutions.
Nasdaq29d
Why Is Novavax (NVAX) Up 13.6% Since Last Earnings Report?
It has been about a month since the last earnings report for Novavax (NVAX). Shares have added about 13.6% in that time frame, outperforming the S&P 500. Will the recent positive trend continue ...
ETF Daily News11d
Novavax (NASDAQ:NVAX) Stock Price Down 5.8% – Time to Sell?
Novavax, Inc. (NASDAQ:NVAX – Get Free Report)’s share price traded down 5.8% during mid-day trading on Monday .The stock traded as low as $7.62 and last traded at $7.80. 1,894,875 shares ...
Nasdaq28d
Novavax Achieves $50Mln Milestone In Sanofi Agreement
NVAX closed Thursday's trading at $9.02 ... views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc. Founded in the late 1990s by Andrew Mariathasan in New York ...
Novavax Inc. stock underperforms Wednesday when compared to competitors
The stock's fall snapped a five-day winning streak.
Nasdaq28d
Novavax advances growth strategy through partnership with Sanofi
Novavax (NVAX) announced progress in Q4 advancing its corporate growth strategy through its partnership with Sanofi (SNY). The company has achieved a milestone associated with its Phase 2/3 ...
Yahoo Finance4d
Novavax, Inc. (NVAX)
But the company trimmed its outlook. Is NVAX stock a sell in December 2024? Novavax, Inc. (Nasdaq: NVAX), a global company advancing protein-based vaccines with its Matrix-M™ adjuvant, today announced ...